Childhood Trauma in Schizophrenia: Exploration of Links Between Gene Expression, Cerebral Morphology and Symptomatology
NCT03355781 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 78
Last updated 2024-01-17
Summary
Childhood trauma is known as a vulnerability factor in schizophrenia. In healthy volunteers, these adversities are linked to a decrease of grey matter of the brain, similar to those observed in schizophrenia.
In a previous study based on Voxel-Based Morphometry (VBM), including 21 schizophrenic patients and 30 healthy volunteers, the investigators shown a negative correlation between emotional neglect (important dimension in childhood trauma) and grey matter decrease. This strong correlation was significantly higher in schizophrenic patients than in healthy volunteers, suggesting a higher genetic predisposition to environmental factors in schizophrenic people.
Currently, interaction between genetic predisposition and environmental stress factors is the major model for understanding in schizophrenia. In order to analyze both effects on human body, particularly on brain, several studies currently focus on the product of genetic expression, the ribonucleic acid (ARN).
The purpose of this study is to provide an explanatory model of links between childhood trauma, candidate gene for schizophrenia expression, cerebral morphology and schizophrenic symptomatology. Using conceptual framework of stress vulnerability, structural equation modeling (SEM) will allow testing causal link between these different variables.
Conditions
Interventions
- DEVICE
-
magnetic resonance imaging (MRI)
brain imaging : structural anatomy, emotional congruence, anatomic connectivity, functional connectivity
- PROCEDURE
-
Blood sample
27,5 ml of blood sample : genetic analysis and biobank
- OTHER
-
Clinical psychiatric evaluation
Global Assessment Scale(GAS),Mini International Neuropsychiatric Interview(MINI),Positive and Negative Symptoms Scale(PANSS),Family Interview for Genetic Studies(FIGS),Calgary Depression Scale for Schizophrenia(CDSS),extrapyramidal side effects evaluation or Simpson-Angus scale evaluation(ESRS),Apathy Evaluation Scale(AES-C),State-Trait Anxiety Inventory(STAI),Beck Depression Inventory(BDI-13),Eysenck Personality Questionnaire-Revised(EPQ-R),Assessment of Schizotypal Personality(SPQ),Emotion Regulation Questionnaire(ERQ),Emotional Reactivity Scale(ERS),Toronto Alexithymia Scale(TAS-20),social anhedonia scale(SAS),Childhood Trauma Questionnaire(CTQ),Clinical-administered Post Traumatic Stress Disorder Scale(CAPS),Wechsler Adult Intelligence Scale(WAIS-III),Trail Making Test(TMT),Pen and paper visuospatial working memory(DOT-test),impulsivity test(GoStop),Stroop test,National Adult Reading Test(NART),Wechsler Adult Intelligence Scale(WAIS-III),Facial Emotion Recognition task(FER)
Sponsors & Collaborators
-
Centre Hospitalier Universitaire de Saint Etienne
lead OTHER
Eligibility
- Min Age
- 18 Years
- Max Age
- 50 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2018-11-14
- Primary Completion
- 2023-11-30
- Completion
- 2023-11-30
Countries
- France
Study Locations
More Related Trials
-
Social Dysfunction and Brain Dysfunction in Patients With Schizophrenia
NCT01903915 ·Status: UNKNOWN
-
Schizophrenia Imaging
NCT01655472 ·Status: UNKNOWN ·Phase: NA
-
Morphological, Structural and Functional Neural Substrates of Quality of Life in Schizophrenia
NCT01295411 ·Status: UNKNOWN ·Phase: NA
-
Brain Imaging, Attention, and Auditory Processing in Schizophrenia
NCT03068806 ·Status: COMPLETED
-
fMRI of Theory of Mind in Schizophrenia and Bipolar Disorder
NCT02834182 ·Status: UNKNOWN ·Phase: NA
-
Characterization of Emotional Processing of Information in Bipolar Disorder and Schizophrenic Patients
NCT02841345 ·Status: UNKNOWN ·Phase: NA
-
Functional Relevance of Dopamine Receptors in Healthy Controls and Patients With Schizophrenia: Characterization Through [11C]NNC-112 and [18F]Fallypride Positron Emission Tomography
NCT00942981 ·Status: COMPLETED
-
Neuroplasticity in TBI and Schizophrenia
NCT03995368 ·Status: COMPLETED ·Phase: NA
-
Immunoinflammatory State Detection and Multimodal Brain Imaging and Electrophysiologic Changes in Schizophrenia
NCT06673966 ·Status: RECRUITING
-
Neuropsychiatric Evaluation of Healthy Volunteers and Adults With Schizophrenia
NCT00001323 ·Status: COMPLETED
-
Involuntary Memories Investigation in Schizophrenia
NCT03209778 ·Status: TERMINATED ·Phase: NA
-
Prediction of Violent Behavior in Patients With Schizophrenia by Multimodal Machine Learning
NCT04520399 ·Status: UNKNOWN
-
Brain Imaging in Early Psychosis
NCT03932188 ·Status: UNKNOWN
-
The Difference of Grey Matter Volume Among the Patients of Schizophrenia
NCT05262790 ·Status: COMPLETED
-
Neurobiological and Neurocognitive Disturbances in First-episode Schizophrenia
NCT00207064 ·Status: COMPLETED ·Phase: NA
-
Emotion Endophenotypes in Schizophrenia
NCT02834208 ·Status: UNKNOWN ·Phase: NA
-
Evaluation of Membrane Phospholipid and Energy Metabolism in Subjects at High Risk of Psychotic Transition
NCT05865652 ·Status: RECRUITING ·Phase: NA
-
Neuroimaging Studies of Neurophysiological Phenotypes in Schizophrenia
NCT01036568 ·Status: COMPLETED
-
Cognitive and Emotional Factors in Visual Exploration Among Patients With Schizophrenia
NCT02874482 ·Status: COMPLETED
-
Cannabis and Thought Disorder in Schizophrenia
NCT03608137 ·Status: TERMINATED ·Phase: NA
-
Research of Anatomo-functional Biomarkers in Schizophrenia
NCT03996122 ·Status: UNKNOWN
-
Value of Voxel-Based Morphometry in Schizophrenia
NCT07108673 ·Status: NOT_YET_RECRUITING
-
Measuring Time Windows in Patients With Schizophrenia and Healthy Controls
NCT00350805 ·Status: COMPLETED
-
Microglia Activation in Schizophrenia
NCT00205608 ·Status: COMPLETED ·Phase: PHASE1
-
Interest of EMDR Schizophrenic Disorders
NCT05164289 ·Status: TERMINATED